Skip to main content
. 2020 Aug 25;15(12):1935–1942. doi: 10.1016/j.jtho.2020.08.018

Table 3.

Adverse Events

Adverse Events CTCAE Grade
All Grade
Grade ≥3
1 2 3 4 5 Total % Total %
Pneumonitis 1 0 3 0 1 5 29.4 4 23.5
Dyspnea 2 0 4 0 0 6 35.3 4 23.5
Hypoalbuminemia 11 3 2 0 0 16 94.1 2 11.8
Lung infection 0 0 2 0 0 2 11.8 2 11.8
Hyponatremia 10 1 0 1 0 12 70.6 1 5.9
General fatigue 3 3 1 0 0 7 41.2 1 5.9
Anemia 6 6 0 0 0 12 70.6 0 0.0
AST increased 10 1 0 0 0 11 64.7 0 0.0
ALT increased 8 2 0 0 0 10 58.8 0 0.0
Cough 4 4 0 0 0 8 47.1 0 0.0
Appetite loss 5 2 0 0 0 7 41.2 0 0.0
Fever 4 2 0 0 0 6 35.3 0 0.0
Hyperglycemia 5 1 0 0 0 6 35.3 0 0.0
ALP increased 3 2 0 0 0 5 29.4 0 0.0
Creatinine increased 5 0 0 0 0 5 29.4 0 0.0
Serum amylase increased 5 0 0 0 0 5 29.4 0 0.0
Hypereosinophilia 4 0 0 0 0 4 23.5 0 0.0
CPK increased 2 1 0 0 0 3 17.6 0 0.0
Proteinuria 2 1 0 0 0 3 17.6 0 0.0
Hyperkalemia 3 0 0 0 0 3 17.6 0 0.0
Hypothyroidism 3 0 0 0 0 3 17.6 0 0.0
Nausea 3 0 0 0 0 3 17.6 0 0.0
Diarrhea 1 1 0 0 0 2 11.8 0 0.0
Thrombocytopenia 2 0 0 0 0 2 11.8 0 0.0
Blood bilirubin increased 2 0 0 0 0 2 11.8 0 0.0
Hypokalemia 2 0 0 0 0 2 11.8 0 0.0
Palpitations 2 0 0 0 0 2 11.8 0 0.0
Vomiting 2 0 0 0 0 2 11.8 0 0.0
Constipation 2 0 0 0 0 2 11.8 0 0.0
Abdominal pain 2 0 0 0 0 2 11.8 0 0.0
Pruritus 2 0 0 0 0 2 11.8 0 0.0
Peripheral sensory neuropathy 2 0 0 0 0 2 11.8 0 0.0
Radiation recall pneumonitisa 1 0 0 0 0 1 5.9 0 0.0

ALP, alkaline phosphatase; ALT, alanine aminotransferase; AST, aspartate aminotransferase; CPK, creatine phosphokinase; CTCAE, Common Terminology Criteria for Adverse Event.

a

In the patient where the exclusion criteria were violated owing to a history of thoracic radiotherapy, an adverse event determined by the central judgment to be radiation recall pneumonitis with a CTCAE grade of 1 occurred. This was treated separately from pneumonitis in this report.